RegulatoryJun 16, 2026, 09:21 AM
Genenta Regains Nasdaq Minimum Bid Price Compliance
AI Summary
Genenta Science S.p.A. announced it has regained compliance with Nasdaq's minimum bid price requirement. The company received a letter from Nasdaq confirming that its American Depositary Shares (ADSs) maintained a closing bid price of $1.00 or more for 10 consecutive business days from June 1 to June 12, 2026. This resolves the previous non-compliance notification issued on April 10, 2026.
Key Highlights
- Genenta Science received notification from Nasdaq regarding regaining compliance.
- Company regained compliance with Nasdaq Listing Rule 5550(a)(2).
- The rule requires a minimum bid price of $1.00 per share.
- Genenta's ADSs traded at or above $1.00 for 10 consecutive business days (June 1-12, 2026).
- Nasdaq previously notified the company of non-compliance on April 10, 2026.
Price Impact
More from GNTA